David Maillard

Title: The Innovations of David Maillard

Introduction

David Maillard is a prominent inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of nine patents to his name, Maillard's work has had a substantial impact on medical treatments.

Latest Patents

Among his latest patents, Maillard has developed crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, along with its salt forms and processes for obtaining them. This solid form is recognized for its utility as a BTK inhibitor, which is crucial in treating various diseases. Additionally, he has improved the process for preparing metformin hydrochloride, an essential drug in the first-line treatment of Type II Diabetes.

Career Highlights

David Maillard has worked with notable companies in the pharmaceutical industry, including Merck Patent GmbH and Poxel. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in drug development.

Collaborations

Maillard has collaborated with esteemed colleagues such as Michael Lange and Clemens Kuehn. These partnerships have fostered a creative environment that has led to the advancement of several important pharmaceutical projects.

Conclusion

David Maillard's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective treatments for various medical conditions.